Answers are grounded in this paper and cite their sources.
There has been a marked expansion in the literature pertaining to the use of immunohistochemical markers in female genital tract pathology, especially with regard to diagnosis. This review provides a survey of the antibodies commonly used in the diagnosis of gynecological lesions grouped as to function or type. Prognostic or predictive markers are also discussed where appropriate, although few of these are of value in everyday practice. It is stressed that when immunohistochemistry is used diagnostically, panels of markers provide better information than reliance on a single antibody.
No takes yet. Share an insight, caveat, or question.
W. Glenn McCluggage (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: